Photoimmunotherapy

Jun 22, 2020

Rakuten Medical Presents Data Characterizing how Photoimmunotherapy Induces Cancer Cell Death and Enhances the Immune Response Preclinically

Sep 30, 2019

Rakuten Medical Releases New, Post-hoc Analysis of Safety, Pharmacokinetic (PK), Immunogenicity and Biomarker Data from its Phase 1 & 1/2a Clinical Trials

May 31, 2019

Rakuten Medical Opens Two New Offices In The Netherlands And Taiwan, Adding New Jobs To Strengthen And Expand Its Global Presence

May 15, 2019

Rakuten Medical Highlights Upcoming Presentations and Activities During the ASCO Annual Meeting, May 31 - June 4, 2019 in Chicago

Apr 08, 2019

Rakuten Medical's ASP-1929 photoimmunotherapy for head and neck cancers to be designated under the Sakigake Designation System for its potential innovativeness and effectiveness

Mar 01, 2019

Rakuten Aspyrian Announces Name Change to Rakuten Medical

Dec 17, 2018

Rakuten Aspyrian Enrolling Phase 3 Trial of ASP-1929 for Head and Neck Cancer

Dec 13, 2018

Transporting the Light Killers: NUST MISiS and MIREA-Russian Technological University Collaborate to Create a Unique Tandem of Organic Molecules and Nanoparticles to Fight Cancer

Aug 23, 2018

Rakuten Aspyrian Raises $150 Million in Series C Financing